Growth hormone receptor agonists and antagonists: From protein expression and purification to long‐acting formulations

Recombinant human growth hormone (rhGH) and GH receptor antagonists (GHAs) are used clinically to treat a range of disorders associated with GH deficiency or hypersecretion, respectively. However, these biotherapeutics can be difficult and expensive to manufacture with multiple challenges from recom...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yue, Kim, Minah, Buckley, Chantal, Maynard, Heather D., Langley, Ries J., Perry, Jo K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2023
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10443362/
https://www.ncbi.nlm.nih.gov/pubmed/37428391
http://dx.doi.org/10.1002/pro.4727

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10443362/
https://www.ncbi.nlm.nih.gov/pubmed/37428391
http://dx.doi.org/10.1002/pro.4727

Ejemplares similares